4//SEC Filing
Waksal Harlan 4
Accession 0000950170-23-063137
CIK 0001327273other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:29 PM ET
Size
20.6 KB
Accession
0000950170-23-063137
Insider Transaction Report
Form 4
Waksal Harlan
DirectorExecutive Chair
Transactions
- Purchase
Common Stock
2023-11-10$2.96/sh+25,000$74,095→ 261,966 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at per share prices ranging from $2.83 to $3.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Lyra Therapeutics, Inc.
CIK 0001327273
Entity typeother
Related Parties
1- filerCIK 0001449008
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 5:29 PM ET
- Size
- 20.6 KB